Please login to bookmark Close
Distribution company Metcash has lost its bid to overturn a decision that found it had to provide employees with a 12-hour break between shifts irrespective of whether the work was ordinary or overtime hours.
Medibank says Deloitte data breach report not relevant in shareholder class action
Please login to bookmark Close
Medibank is seeking to shield from a shareholder class action an “irrelevant” post-incident report by Deloitte into its massive October 2022 data breach.
Judge balks at $10M registration bill in stolen wages class action
Please login to bookmark Close
The judge overseeing a $180.4 million settlement in a stolen wages class action has railed against Shine Lawyers’ $10 million bill for the costs of registration, saying “something has gone seriously wrong”.
Freehills the firm of choice for MinRes, WiseTech as bosses face scrutiny
Please login to bookmark Close
As Mineral Resources and WiseTech face shareholder glare over accusations levelled at their billionaire bosses, it is Herbert Smith Freehills that their embattled boards have turned to.
Judge rejects franchisees’ ‘colourable’ cross-claims against United Petroleum
Please login to bookmark Close
United Petroleum will not face cross-claims by franchisees, with a judge calling the bid “a very colourable application” to create overlap with a class action in the Supreme Court.
Salter Brothers sues insurer to cover $3.5M in costs to defend client’s lawsuit
Please login to bookmark Close
Investment manager Salter Brothers has sued XL Insurance, saying it has “unreasonably delayed” covering the costs of defending a former client’s lawsuit alleging misleading conduct.
ASIC wins case over life insurer’s misleading ‘pre-existing condition’ term
Please login to bookmark Close
ASIC has won its case against insurer HCF Life over a pre-existing condition term that was likely to mislead the public, but failed to convince the court that it was an unfair contract term.
AstraZeneca sues to put the brakes on Brilinta generic
Please login to bookmark Close
AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta.
ASIC warns financial services firms of risk of governance lag with AI use
Please login to bookmark Close
The corporate regulator has warned financial services and credit licensees to get ahead of the curve in regulating the use of AI, particularly in the face of novel risks that include algorithm bias.
Santos’ net zero plan ‘little more than speculation’, trial court told
Please login to bookmark Close
Santos’ plan to reach net zero greenhouse gas emissions by 2040 was “little more than a series of speculations”, a shareholder group has said on the first day of trial in a landmark greenwashing case.